# 002-covid_therapeutics_USA

Published stories here:

[Covid-19 antiviral access: uneven supply patterns hinder US rollout](https://www.pharmaceutical-technology.com/features/covid-19-antiviral-access-uneven-supply-patterns-hinder-us-rollout/)

[Molnupiravir supplies dominate in times of Paxlovid scarcity](https://www.pharmaceutical-technology.com/features/molnupiravir-supplies-dominate-in-times-of-paxlovid-scarcity/)

